Takahashi, S., Sakamoto, Y., Denda, T., Takashima, A., Komatsu, Y., Nakamura, M., . . . Ishioka, C. (2021). Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer. Cancer science, 112(4), 1567-1578. https://doi.org/10.1111/cas.14841
Citácia podle Chicago (17th ed.)Takahashi, Shin, et al. "Advanced Colorectal Cancer Subtypes (aCRCS) Help Select Oxaliplatin‐based or Irinotecan‐based Therapy for Colorectal Cancer." Cancer Science 112, no. 4 (2021): 1567-1578. https://doi.org/10.1111/cas.14841.
Citácia podľa MLA (8th ed.)Takahashi, Shin, et al. "Advanced Colorectal Cancer Subtypes (aCRCS) Help Select Oxaliplatin‐based or Irinotecan‐based Therapy for Colorectal Cancer." Cancer Science, vol. 112, no. 4, 2021, pp. 1567-1578, https://doi.org/10.1111/cas.14841.